REG - CVS Group plc - Exercise of Options

CVSAnnouncement

29/01/2021 12:00

RNS Number : 2760N
  
CVS Group plc
  
29 January 2021
  
 

29 January 2021
CVS Group plc
("CVS" or the "Company")
Exercise of Options
CVS, one of the UK's leading providers of integrated veterinary services, confirms that certain employees have exercised options during January under the Company's Save As You Earn (SAYE) 2021 scheme (together, the "SAYE Exercise") totalling 55,559 ordinary shares of 0.2 pence each ("Ordinary Shares").
18,003 of the Ordinary Shares arising from the SAYE Exercise were satisfied out of the Company's existing Employee Benefit Trust ("EBT") and, as at the date of this announcement, the remaining number of Ordinary Shares held by the EBT is 710. A further 37,556 new Ordinary Shares were issued during the month to satisfy the balance of Ordinary Shares arising from the SAYE Exercise. Admission of these 37,556 new Ordinary Shares has been satisfied via the Company's block listing, application for which became effective on 11 January 2021.
Following the issue of the 37,556 new Ordinary Shares, which rank pari passu in all aspects with the Company's existing Ordinary Shares, the Company has a total issued share capital at the date of this announcement of 70,692,515 Ordinary Shares, each carrying one voting right.
The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,692,515. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
Contacts:
CVS Group Plc                                                 Tel: 01379 644288
Juliet Dearlove, Company Secretary              
 
N+1 Singer (Nominated Adviser & Broker)    Tel: 020 7496 3000
Aubrey Powell/ Jen Boorer (Corporate Finance)
Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ALSDKFBDOBKDBDB